WALTHAM, Mass., Sept. 05, 2023 Invivyd, Inc. , a clinical-stage biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases, today announced the.
Pyxis Oncology to Participate in Two Upcoming Investment Conferences streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Longwood Healthcare Leaders to Convene Top Biotech and Pharmaceutical Leaders and Researchers finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Pyxis Oncology (NASDAQ:PYXS – Get Free Report) posted its quarterly earnings results on Friday. The company reported ($0.41) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.65) by $0.24, MarketWatch Earnings reports. Pyxis Oncology Stock Up 6.6 % PYXS stock opened at $2.58 on Monday. The business has a 50 day moving […]